Marshall Wace North America’s Accelerate Diagnostics AXDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-1,626
| Closed | -$135K | – | 1387 |
|
|
2021
Q1 | $135K | Sell |
1,626
-1,822
| -53% | -$151K | ﹤0.01% | 1395 |
|
|
2020
Q4 | $261K | Hold |
3,448
| – | – | ﹤0.01% | 1188 |
|
|
2020
Q3 | $368K | Sell |
3,448
-1,818
| -35% | -$194K | ﹤0.01% | 1031 |
|
|
2020
Q2 | $799K | Buy |
5,266
+4,030
| +326% | +$611K | 0.01% | 818 |
|
|
2020
Q1 | $103K | Buy |
+1,236
| New | +$103K | ﹤0.01% | 991 |
|
|
2019
Q4 | – | Sell |
-1,349
| Closed | -$251K | – | 1280 |
|
|
2019
Q3 | $251K | Buy |
+1,349
| New | +$251K | ﹤0.01% | 922 |
|
|
2017
Q4 | – | Sell |
-13,975
| Closed | -$3.07M | – | 1366 |
|
|
2017
Q3 | $3.07M | Buy |
13,975
+9,481
| +211% | +$2.09M | 0.02% | 681 |
|
|
2017
Q2 | $1.21M | Buy |
+4,494
| New | +$1.21M | 0.01% | 880 |
|